State of the Art: Evaluation and Medical Management of Angina with NonObstructive Coronary Artery Disease
Published: November 10, 2025
- Non-obstructive coronary artery disease (NOCA) is common, carries significant cardiovascular risk, and requires accurate detection and proactive management to improve outcomes.
- Individualized treatment strategies and intensive risk factor modification—including lipid-lowering and antihypertensive therapies—are essential for patients with NOCA.
- Ongoing follow-up, recognition in guidelines, and emerging therapies are shaping the evolving care pathway for NOCA patients.
Recommended Reading
- Hub - Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease
- Hub - 2025 High Blood Pressure Guideline published in Hypertension
- Hub - 2021 Guideline for the Evaluation and Diagnosis of Chest Pain
- Hub - 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization
- Hub - 2018 Guideline on the Management of Blood Cholesterol